For PhRMA, There Is Good News And Bad News In The Mid-Term Elections
Executive Summary
The anti-government intervention sentiment coming to Congress in January with the newly elected Republicans presents a tactical challenge to lobbying efforts by the Pharmaceutical Research and Manufacturers of America.